Pricing Log in Create free account

Annexon, Inc. (ANNX) vs Candel Therapeutics, Inc. (CADL)

Annexon, Inc. and Candel Therapeutics, Inc. are both Biotechnology companies. Annexon, Inc. and Candel Therapeutics, Inc. are of similar size ($682.5M and $681.8M). Across the 9 metrics below, Candel Therapeutics, Inc. leads on 6 and Annexon, Inc. on 3.

Valuation

Metric ANNX CADL Biotechnology median
P/E n/m n/m 8.50
P/S n/m 4,857.08 9.71
P/B 3.68 4.81 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 3,661.00 9.21
Earnings yield (34.02%) (17.22%) (33.15%)
Free cash flow yield (28.19%) (9.44%) (25.50%)

Profitability

Metric ANNX CADL Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (105.26%) (81.84%) (56.36%)
Return on assets (79.38%) (56.37%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANNX CADL Biotechnology median
Revenue growth (TTM) — 0.00% 6.02%
EPS growth (last fiscal year) (32.67%) 58.62% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANNX CADL Biotechnology median
Debt to equity 0.00 0.38 0.00
Current ratio 5.53 16.09 4.72
Net debt to EBITDA 1.11 1.53 0.96

Dividend

Metric ANNX CADL Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ANNX CADL Biotechnology median
Market cap 682.49m 681.78m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack